Parallel Advisors’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $15.9K | Buy |
1,361
+458
| +51% | +$6.54K | ﹤0.01% | 2728 |
|
|
2026
Q1 | $15.2K | Sell |
903
-160
| -15% | -$2.86K | ﹤0.01% | 2589 |
|
|
2025
Q4 | $17K | Buy |
1,063
+121
| +13% | +$1.8K | ﹤0.01% | 2372 |
|
|
2025
Q3 | $11.6K | Buy |
942
+427
| +83% | +$5.01K | ﹤0.01% | 2488 |
|
|
2025
Q2 | $5.93K | Sell |
515
-1,189
| -70% | -$14.1K | ﹤0.01% | 2676 |
|
|
2025
Q1 | $25.5K | Buy |
1,704
+519
| +44% | +$8.69K | ﹤0.01% | 2010 |
|
|
2024
Q4 | $20.5K | Sell |
1,185
-93
| -7% | -$1.79K | ﹤0.01% | 2140 |
|
|
2024
Q3 | $23.7K | Buy |
1,278
+31
| +2% | +$623 | ﹤0.01% | 2002 |
|
|
2024
Q2 | $25.3K | Buy |
1,247
+134
| +12% | +$2.37K | ﹤0.01% | 1852 |
|
|
2024
Q1 | $19K | Sell |
1,113
-241
| -18% | -$3.79K | ﹤0.01% | 2010 |
|
|
2023
Q4 | $23.9K | Buy |
1,354
+112
| +9% | +$2.26K | ﹤0.01% | 1821 |
|
|
2023
Q3 | $29.8K | Hold |
1,242
| – | – | ﹤0.01% | 1646 |
|
|
2023
Q2 | $28.9K | Sell |
1,242
-33
| -3% | -$746 | ﹤0.01% | 1676 |
|
|
2023
Q1 | $28.1K | Hold |
1,275
| – | – | ﹤0.01% | 1659 |
|
|
2022
Q4 | $25.8K | Buy |
1,275
+69
| +6% | +$1.34K | ﹤0.01% | 1590 |
|
|
2022
Q3 | $16K | Buy |
1,206
+404
| +50% | +$6.81K | ﹤0.01% | 1771 |
|
|
2022
Q2 | $16K | Sell |
802
-149
| -16% | -$3.96K | ﹤0.01% | 1756 |
|
|
2022
Q1 | $31K | Buy |
951
+95
| +11% | +$2.66K | ﹤0.01% | 1515 |
|
|
2021
Q4 | $19K | Buy |
856
+196
| +30% | +$5.11K | ﹤0.01% | 1808 |
|
|
2021
Q3 | $18K | Hold |
660
| – | – | ﹤0.01% | 1784 |
|
|
2021
Q2 | $26K | Hold |
660
| – | – | ﹤0.01% | 1530 |
|
|
2021
Q1 | $19K | Hold |
660
| – | – | ﹤0.01% | 1602 |
|
|
2020
Q4 | $17K | Sell |
660
-476
| -42% | -$9.72K | ﹤0.01% | 1546 |
|
|
2020
Q3 | $17K | Sell |
1,136
-372
| -25% | -$7.8K | ﹤0.01% | 1509 |
|
|
2020
Q2 | $30K | Buy |
1,508
+645
| +75% | +$11.6K | ﹤0.01% | 1238 |
|
|
2020
Q1 | $8K | Buy |
863
+608
| +238% | +$17K | ﹤0.01% | 1694 |
|
|
2019
Q4 | $10K | Sell |
255
-1,579
| -86% | -$70.9K | ﹤0.01% | 1715 |
|
|
2019
Q3 | $86K | Buy |
1,834
+24
| +1% | +$1.12K | 0.01% | 764 |
|
|
2019
Q2 | $95K | Sell |
1,810
-154
| -8% | -$9.03K | 0.01% | 675 |
|
|
2019
Q1 | $135K | Buy |
1,964
+200
| +11% | +$13.4K | 0.02% | 510 |
|
|
2018
Q4 | $105K | Buy |
1,764
+130
| +8% | +$11.2K | 0.01% | 516 |
|
|
2018
Q3 | $189K | Buy |
1,634
+691
| +73% | +$78K | 0.02% | 401 |
|
|
2018
Q2 | $119K | Hold |
943
| – | – | 0.02% | 490 |
|
|
2018
Q1 | $102K | Hold |
943
| – | – | 0.02% | 492 |
|
|
2017
Q4 | $103K | Hold |
943
| – | – | 0.02% | 475 |
|
|
2017
Q3 | $98K | Sell |
943
-65
| -6% | -$6.3K | 0.02% | 486 |
|
|
2017
Q2 | $101K | Buy |
1,008
+117
| +13% | +$12.6K | 0.02% | 471 |
|
|
2017
Q1 | $101K | Buy |
891
+223
| +33% | +$25.9K | 0.02% | 439 |
|
|
2016
Q4 | $80K | Buy |
+668
| New | +$74K | 0.02% | 442 |
|
Other funds holding CLB
CAMG
VCM
VPM
HA
Parallel Advisors's CLB Position: Q2 2026 in Review
Parallel Advisors increased its Core Laboratories (CLB) stake by 51% in Q2 2026, buying an estimated $6.54K and bringing the position to 1,361 shares worth $15.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2728.
Parallel Advisors first reported a position in CLB in Q4 2016 and has held it in 39 quarters since. The position peaked at $189K in Q3 2018. 146 funds tracked by Wall St. Rank hold CLB as of Q2 2026.
- Parallel Advisors held 1,361 shares of Core Laboratories worth $15.9K as of Q2 2026.
- Parallel Advisors bought 458 Core Laboratories shares in Q2 2026, an estimated $6.54K.
- Core Laboratories made up ﹤0.01% of Parallel Advisors's portfolio in Q2 2026, its #2728 holding.
- Parallel Advisors first reported a position in Core Laboratories in Q4 2016 and has held it in 39 quarters since.
- Parallel Advisors's Core Laboratories position peaked at $189K in Q3 2018.
- 146 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.
Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.